DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management

Explore the latest findings presented at ERA 2025 in Vienna, Austria, through concise video briefs, where leading experts analyze cutting-edge clinical trial data on emerging nonsteroidal mineralocorticoid receptor antagonist therapy in patients with CKD, T2D, and heart failure.

LikeLikedUnlike

Episodes 1-4 of 4

Topline Results of the CONFIDENCE Trial
CME/CE
Topline Results of the CONFIDENCE Trial
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
  Peer
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
CME/CE
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
- Finnian R. McCausland, MD
  Peer
Albuminuria Change and Finerenone's Effect on CV Outcomes
CME/CE
Albuminuria Change and Finerenone's Effect on CV Outcomes
- Finnian R. McCausland, MD
  Peer
The CONFIDENCE Trial: Data Insights
CME/CE
The CONFIDENCE Trial: Data Insights
- prof. Hiddo Heerspink
  Peer
advertisement

CME/CE Series

CME/CE Topic Areas

Featured Education Partners

Spotlight On:

Lifestyle

Trending Topics

DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management

Episodes 1-4 of 4

Program Chapters

Segment Chapters

Playlist:

Recommended

Episodes 1-4 of 4

Title

Share on ReachMD

Program Chapters

Segment Chapters

Playlist:

Recommended

Get a Dose of ReachMD in Your Inbox and Practice Smarter Medicine